Just published: effects of disease prevalence and feedback on dermatological decision making

Kira Prentice, Head of Product - DiagnosUs
February 2, 2022

Imagine that you are a dermatologist. You spend the morning seeing patients who have been referred to you for suspicion of skin cancer. Many of them do, in fact, have skin lesions that require treatment. We would say that disease "prevalence" was high in this set of patients.

Suppose that you next spend the afternoon giving annual screening exams to members of the general population. Here disease prevalence will be low. Would your morning’s work influence your decisions about patients in the afternoon?

In collaboration with Centaur Labs, Jeremy M Wolfe, PhD, Professor of Ophthalmology & Radiology at Harvard Medical School conducted a study published this month in Cognitive Research: Principles and Implications (CRPI) that tackled this question. We know from other contexts that recent history can influence current decisions and we know that target prevalence has an impact on decisions.

In this study, Centaur Labs collected decisions about skin lesions from individuals with varying degrees of expertise using our proprietary medical imaging labeling app, DiagnosUs. Over 300,000 trials were collected in DiagnosUs over five days, with 803 participants in the study. This allowed the researcher to examine the effects of feedback history and prevalence in a single study.

This research finds that feedback educates observers, causing them to become more liberal when targets (diagnoses of melanoma) have been relatively common and more conservative when those targets are rare. The effects of a block of trials with feedback can last for days with those effects showing up when the observer takes up a similar task again. It may be possible to use the educational effects of feedback when it is desirable to shift an observer's criterion, especially if the subsequent task does not involve reliable feedback.

Read the full study at Cognitive Research: Principles and Implications (CRPI).

Related posts

September 2, 2022

Consensus partners with Centaur Labs to generate high-quality and scalable scientific data labels

The new AI-powered scientific search engine, Consensus has officially announced its partnership with Centaur Labs to generate high-quality and scalable scientific data labels.

Continue reading →
December 8, 2020

When experts disagree, who do you trust for your medical AI?

Learn the how to mitigate the impact of medical error in your data labeling pipeline by intelligently aggregating multiple expert opinions together

Continue reading →